205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.64%
Revenue growth exceeding 1.5x AVGO's 0.59%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
8.64%
Gross profit growth exceeding 1.5x AVGO's 0.51%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.64%
Other expenses growth while AVGO reduces costs. John Neff would investigate differences.
8.64%
Operating expenses growth 50-75% of AVGO's 12.43%. Bruce Berkowitz would examine efficiency.
8.64%
Total costs growth 1.25-1.5x AVGO's 6.00%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.64%
EBITDA growth below 50% of AVGO's 62.84%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
8.64%
Operating income growth while AVGO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-8.64%
Other expenses reduction while AVGO shows 3.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
194.62%
Net income growth while AVGO declines. John Neff would investigate advantages.
187.09%
Net margin growth while AVGO declines. John Neff would investigate advantages.
150.00%
EPS growth while AVGO declines. John Neff would investigate advantages.
150.00%
Diluted EPS growth while AVGO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.